Form D Explorer

Inspect source fieldsReport a record issue

Form D — Montara Therapeutics, Inc.

0002008775-25-000001 · filed Mar 13, 2025

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry
Biotechnology
Exemptions
Rule 506(b)
Reported offering amount
$19,999,995
Reported amount sold
$19,999,995
Minimum investment
$0
Investors
—
Sales commission
—
Finders' fees
—

Issuer

Name
Montara Therapeutics, Inc.
CIK
2008775
Entity
Corporation
Jurisdiction
DELAWARE
Year incorporated
2022
Address
135 MISSISSIPPI STREET
SAN FRANCISCO, California 94107
Phone
310-463-6172

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

View the original filing on SEC EDGAR ↗